-
1
-
-
38949085520
-
Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey II
-
Nieminen MS, Harjola VP, Hochadel M, Drexler H, Komajda M, Brutsaert D, Dickstein K, Ponikowski P, Tavazzi L, Follath F, Lopez-Sendon JL. Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey II. Eur J Heart Fail. 2008;10:140-148. doi: 10.1016/j.ejheart.2007.12.012.
-
(2008)
Eur J Heart Fail.
, vol.10
, pp. 140-148
-
-
Nieminen, M.S.1
Harjola, V.P.2
Hochadel, M.3
Drexler, H.4
Komajda, M.5
Brutsaert, D.6
Dickstein, K.7
Ponikowski, P.8
Tavazzi, L.9
Follath, F.10
Lopez-Sendon, J.L.11
-
2
-
-
67651165572
-
Sex-based cardiac physiology
-
Luczak ED, Leinwand LA. Sex-based cardiac physiology. Annu Rev Physiol. 2009;71:1-18. doi: 10.1146/annurev.physiol.010908.163156.
-
(2009)
Annu Rev Physiol.
, vol.71
, pp. 1-18
-
-
Luczak, E.D.1
Leinwand, L.A.2
-
3
-
-
33745197797
-
Therapeutic implications of the gender-specific aspects of cardiovascular disease
-
Regitz-Zagrosek V. Therapeutic implications of the gender-specific aspects of cardiovascular disease. Nat Rev. 2006;5:425-438.
-
(2006)
Nat Rev.
, vol.5
, pp. 425-438
-
-
Regitz-Zagrosek, V.1
-
4
-
-
84873836880
-
Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection
-
Strba M, Popelová O, Vávrová A, Jirkovský E, Kovaíková P, Geršl V, Simnek T. Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection. Antioxid Redox Signal. 2013;18:899-929. doi: 10.1089/ars.2012.4795.
-
(2013)
Antioxid Redox Signal.
, vol.18
, pp. 899-929
-
-
Strba, M.1
Popelová, O.2
Vávrová, A.3
Jirkovský, E.4
Kovaíková, P.5
Geršl, V.6
Simnek, T.7
-
5
-
-
3042698689
-
Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults
-
Hequet O, Le QH, Moullet I, Pauli E, Salles G, Espinouse D, Dumontet C, Thieblemont C, Arnaud P, Antal D, Bouafia F, Coiffier B. Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults. J Clin Oncol. 2004;22:1864-1871. doi: 10.1200/JCO.2004.06.033.
-
(2004)
J Clin Oncol.
, vol.22
, pp. 1864-1871
-
-
Hequet, O.1
Le, Q.H.2
Moullet, I.3
Pauli, E.4
Salles, G.5
Espinouse, D.6
Dumontet, C.7
Thieblemont, C.8
Arnaud, P.9
Antal, D.10
Bouafia, F.11
Coiffier, B.12
-
6
-
-
77953366369
-
Males still dominate animal studies
-
Zucker I, Beery AK. Males still dominate animal studies. Nature. 2010;465:690. doi: 10.1038/465690a.
-
(2010)
Nature.
, vol.465
, pp. 690
-
-
Zucker, I.1
Beery, A.K.2
-
7
-
-
84886015801
-
Sex-related differences in mast cell activity and doxorubicin toxicity: A study in spontaneously hypertensive rats
-
Zhang J, Knapton A, Lipshultz SE, Cochran TR, Hiraragi H, Herman EH. Sex-related differences in mast cell activity and doxorubicin toxicity: a study in spontaneously hypertensive rats. Toxicol Pathol. 2014;42:361-375. doi: 10.1177/0192623313482778.
-
(2014)
Toxicol Pathol.
, vol.42
, pp. 361-375
-
-
Zhang, J.1
Knapton, A.2
Lipshultz, S.E.3
Cochran, T.R.4
Hiraragi, H.5
Herman, E.H.6
-
8
-
-
0023856705
-
The effect of chronic adriamycin treatment on heart kidney and liver tissue of male and female rat
-
Julicher RH, Sterrenberg L, Haenen GR, Bast A, Noordhoek J. The effect of chronic adriamycin treatment on heart kidney and liver tissue of male and female rat. Arch Toxicol. 1988;61:275-281.
-
(1988)
Arch Toxicol.
, vol.61
, pp. 275-281
-
-
Julicher, R.H.1
Sterrenberg, L.2
Haenen, G.R.3
Bast, A.4
Noordhoek, J.5
-
9
-
-
0022602127
-
Time-course study on doxorubicin-induced nephropathy and cardiomyopathy in male and female LOU/M/Wsl rats: Lack of evidence for a causal relationship
-
van Hoesel QG, Steerenberg PA, Dormans JA, de Jong WH, de Wildt DJ, Vos JG. Time-course study on doxorubicin-induced nephropathy and cardiomyopathy in male and female LOU/M/Wsl rats: lack of evidence for a causal relationship. J Natl Cancer Inst. 1986;76:299-307.
-
(1986)
J Natl Cancer Inst.
, vol.76
, pp. 299-307
-
-
Van Hoesel, Q.G.1
Steerenberg, P.A.2
Dormans, J.A.3
De Jong, W.H.4
De Wildt, D.J.5
Vos, J.G.6
-
10
-
-
33947239659
-
The failing heart-an engine out of fuel
-
Neubauer S. The failing heart-an engine out of fuel. N Engl J Med. 2007;356:1140-1151. doi: 10.1056/NEJMra063052.
-
(2007)
N Engl J Med.
, vol.356
, pp. 1140-1151
-
-
Neubauer, S.1
-
12
-
-
84871696392
-
Inhibition of AMPK signalling by doxorubicin: At the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress
-
Gratia S, Kay L, Potenza L, Seffouh A, Novel-Chaté V, Schnebelen C, Sestili P, Schlattner U, Tokarska-Schlattner M. Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress. Cardiovasc Res. 2012;95:290-299. doi: 10.1093/cvr/cvs134.
-
(2012)
Cardiovasc Res.
, vol.95
, pp. 290-299
-
-
Gratia, S.1
Kay, L.2
Potenza, L.3
Seffouh, A.4
Novel-Chaté, V.5
Schnebelen, C.6
Sestili, P.7
Schlattner, U.8
Tokarska-Schlattner, M.9
-
13
-
-
84859915614
-
Anthracyclines and mitochondria
-
Mordente A, Meucci E, Silvestrini A, Martorana GE, Giardina B. Anthracyclines and mitochondria. Adv Exp Med Biol. 2012;942:385-419. doi: 10.1007/978-94-007-2869-1-18.
-
(2012)
Adv Exp Med Biol.
, vol.942
, pp. 385-419
-
-
Mordente, A.1
Meucci, E.2
Silvestrini, A.3
Martorana, G.E.4
Giardina, B.5
-
14
-
-
84867608210
-
Chronic anthracycline cardiotoxicity: Molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways
-
Jirkovsky E, Popelová O, Kriváková-Stanková P, Vávrová A, Hroch M, Hasková P, Brcáková-Dolezelová E, Micuda S, Adamcová M, Simnek T, Cervinková Z, Gersl V, Sterba M. Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways. J Pharmacol Exp Ther. 2012;343:468-478. doi: 10.1124/jpet.112.198358.
-
(2012)
J Pharmacol Exp Ther.
, vol.343
, pp. 468-478
-
-
Jirkovsky, E.1
Popelová, O.2
Kriváková-Stanková, P.3
Vávrová, A.4
Hroch, M.5
Hasková, P.6
Brcáková-Dolezelová, E.7
Micuda, S.8
Adamcová, M.9
Simnek, T.10
Cervinková, Z.11
Gersl, V.12
Sterba, M.13
-
15
-
-
33847420521
-
AMP-activated protein kinase alpha2 deficiency affects cardiac cardiolipin homeostasis and mitochondrial function
-
Athéa Y, Viollet B, Mateo P, Rousseau D, Novotova M, Garnier A, Vaulont S, Wilding JR, Grynberg A, Veksler V, Hoerter J, Ventura-Clapier R. AMP-activated protein kinase alpha2 deficiency affects cardiac cardiolipin homeostasis and mitochondrial function. Diabetes. 2007;56:786-794. doi: 10.2337/db06-0187.
-
(2007)
Diabetes.
, vol.56
, pp. 786-794
-
-
Athéa, Y.1
Viollet, B.2
Mateo, P.3
Rousseau, D.4
Novotova, M.5
Garnier, A.6
Vaulont, S.7
Wilding, J.R.8
Grynberg, A.9
Veksler, V.10
Hoerter, J.11
Ventura-Clapier, R.12
-
16
-
-
84893109080
-
A role for peroxisome proliferator-activated receptor coactivator 1 (PGC-1) in the regulation of cardiac mitochondrial phospholipid biosynthesis
-
Lai L, Wang M, Martin OJ, Leone TC, Vega RB, Han X, Kelly DP. A role for peroxisome proliferator-activated receptor ? coactivator 1 (PGC-1) in the regulation of cardiac mitochondrial phospholipid biosynthesis. J Biol Chem. 2014;289:2250-2259. doi: 10.1074/jbc.M113.523654.
-
(2014)
J Biol Chem.
, vol.289
, pp. 2250-2259
-
-
Lai, L.1
Wang, M.2
Martin, O.J.3
Leone, T.C.4
Vega, R.B.5
Han, X.6
Kelly, D.P.7
-
17
-
-
0031016894
-
Age-related pharmacokinetics of daunorubicin and daunorubicinol following intravenous bolus daunorubicin administration in the rat
-
Cusack BJ, Young SP, Vestal RE, Olson RD. Age-related pharmacokinetics of daunorubicin and daunorubicinol following intravenous bolus daunorubicin administration in the rat. Cancer Chemother Pharmacol. 1997;39:505-512. doi: 10.1007/s002800050606.
-
(1997)
Cancer Chemother Pharmacol.
, vol.39
, pp. 505-512
-
-
Cusack, B.J.1
Young, S.P.2
Vestal, R.E.3
Olson, R.D.4
-
18
-
-
0037680647
-
The effect of age on the early disposition of doxorubicin
-
Li J, Gwilt PR. The effect of age on the early disposition of doxorubicin. Cancer Chemother Pharmacol. 2003;51:395-402. doi: 10.1007/ s00280-002-0554-z.
-
(2003)
Cancer Chemother Pharmacol.
, vol.51
, pp. 395-402
-
-
Li, J.1
Gwilt, P.R.2
-
19
-
-
0024559951
-
Doxorubicin toxicity and pharmacokinetics in old and young rats
-
Colombo T, Donelli MG, Urso R, Dallarda S, Bartosek I, Guaitani A. Doxorubicin toxicity and pharmacokinetics in old and young rats. Exp Gerontol. 1989;24:159-171.
-
(1989)
Exp Gerontol.
, vol.24
, pp. 159-171
-
-
Colombo, T.1
Donelli, M.G.2
Urso, R.3
Dallarda, S.4
Bartosek, I.5
Guaitani, A.6
-
20
-
-
39149139006
-
Treatment with an adenoviral vector encoding hepatocyte growth factor mitigates established cardiac dysfunction in doxorubicin-induced cardiomyopathy
-
Esaki M, Takemura G, Kosai K, Takahashi T, Miyata S, Li L, Goto K, Maruyama R, Okada H, Kanamori H, Ogino A, Ushikoshi H, Minatoguchi S, Fujiwara T, Fujiwara H. Treatment with an adenoviral vector encoding hepatocyte growth factor mitigates established cardiac dysfunction in doxorubicin-induced cardiomyopathy. Am J Physiol. 2008;294:H1048-1057.
-
(2008)
Am J Physiol.
, vol.294
, pp. H1048-1057
-
-
Esaki, M.1
Takemura, G.2
Kosai, K.3
Takahashi, T.4
Miyata, S.5
Li, L.6
Goto, K.7
Maruyama, R.8
Okada, H.9
Kanamori, H.10
Ogino, A.11
Ushikoshi, H.12
Minatoguchi, S.13
Fujiwara, T.14
Fujiwara, H.15
-
21
-
-
78549271520
-
Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapy
-
Zhao Y, McLaughlin D, Robinson E, Harvey AP, Hookham MB, Shah AM, McDermott BJ, Grieve DJ. Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapy. Cancer Res. 2010;70:9287-9297. doi: 10.1158/0008-5472.CAN-10-2664.
-
(2010)
Cancer Res.
, vol.70
, pp. 9287-9297
-
-
Zhao, Y.1
McLaughlin, D.2
Robinson, E.3
Harvey, A.P.4
Hookham, M.B.5
Shah, A.M.6
McDermott, B.J.7
Grieve, D.J.8
-
22
-
-
55849109642
-
A mouse model for juvenile doxorubicin-induced cardiac dysfunction
-
Zhu W, Shou W, Payne RM, Caldwell R, Field LJ. A mouse model for juvenile doxorubicin-induced cardiac dysfunction. Pediatr Res. 2008;64:488-494. doi: 10.1203/PDR.0b013e318184d732.
-
(2008)
Pediatr Res.
, vol.64
, pp. 488-494
-
-
Zhu, W.1
Shou, W.2
Payne, R.M.3
Caldwell, R.4
Field, L.J.5
-
23
-
-
2442646648
-
Interleukin-6 and cardiovascular diseases
-
Kanda T, Takahashi T. Interleukin-6 and cardiovascular diseases. Jpn Heart J. 2004;45:183-193.
-
(2004)
Jpn Heart J.
, vol.45
, pp. 183-193
-
-
Kanda, T.1
Takahashi, T.2
-
24
-
-
84887609004
-
Regulation of expression of atrial and brain natriuretic peptide, biomarkers for heart development and disease
-
Sergeeva IA, Christoffels VM. Regulation of expression of atrial and brain natriuretic peptide, biomarkers for heart development and disease. Biochim Biophys Acta. 2013;1832:2403-2413. doi: 10.1016/j. bbadis.2013.07.003.
-
(2013)
Biochim Biophys Acta.
, vol.1832
, pp. 2403-2413
-
-
Sergeeva, I.A.1
Christoffels, V.M.2
-
25
-
-
0019817511
-
Mechanism of adriamycin cardiotoxicity: Evidence for oxidative stress
-
Olson RD, Boerth RC, Gerber JG, Nies AS. Mechanism of adriamycin cardiotoxicity: evidence for oxidative stress. Life Sci. 1981;29:1393-1401.
-
(1981)
Life Sci.
, vol.29
, pp. 1393-1401
-
-
Olson, R.D.1
Boerth, R.C.2
Gerber, J.G.3
Nies, A.S.4
-
26
-
-
33845647342
-
Adriamycin-induced oxidative mitochondrial cardiotoxicity
-
Berthiaume JM, Wallace KB. Adriamycin-induced oxidative mitochondrial cardiotoxicity. Cell Biol Toxicol. 2007;23:15-25. doi: 10.1007/ s10565-006-0140-y.
-
(2007)
Cell Biol Toxicol.
, vol.23
, pp. 15-25
-
-
Berthiaume, J.M.1
Wallace, K.B.2
-
27
-
-
84858693977
-
Anthracycline cardiotoxicity
-
Menna P, Paz OG, Chello M, Covino E, Salvatorelli E, Minotti G. Anthracycline cardiotoxicity. Expert Opin Drug Saf. 2012;11(suppl 1):S21-S36. doi: 10.1517/14740338.2011.589834.
-
(2012)
Expert Opin Drug Saf.
, vol.11
, pp. S21-S36
-
-
Menna, P.1
Paz, O.G.2
Chello, M.3
Covino, E.4
Salvatorelli, E.5
Minotti, G.6
-
28
-
-
84860523994
-
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
-
Octavia Y, Tocchetti CG, Gabrielson KL, Janssens S, Crijns HJ, Moens AL. Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. J Mol Cell Cardiol. 2012;52:1213-1225. doi: 10.1016/j.yjmcc.2012.03.006.
-
(2012)
J Mol Cell Cardiol.
, vol.52
, pp. 1213-1225
-
-
Octavia, Y.1
Tocchetti, C.G.2
Gabrielson, K.L.3
Janssens, S.4
Crijns, H.J.5
Moens, A.L.6
-
29
-
-
33644873817
-
Why females live longer than males: Control of longevity by sex hormones
-
Viña J, Borrás C, Gambini J, Sastre J, Pallardó FV. Why females live longer than males: control of longevity by sex hormones. Sci Aging Knowledge Environ. 2005;2005:pe17. doi: 10.1126/sageke.2005.23.pe17.
-
(2005)
Sci Aging Knowledge Environ.
, vol.2005
, pp. pe17
-
-
Viña, J.1
Borrás, C.2
Gambini, J.3
Sastre, J.4
Pallardó, F.V.5
-
30
-
-
57349115353
-
Estrogenic control of mitochondrial function and biogenesis
-
Klinge CM. Estrogenic control of mitochondrial function and biogenesis. J Cell Biochem. 2008;105:1342-1351. doi: 10.1002/jcb.21936.
-
(2008)
J Cell Biochem.
, vol.105
, pp. 1342-1351
-
-
Klinge, C.M.1
-
31
-
-
84893463710
-
Doxorubicin-induced carbonylation and degradation of cardiac myosin binding protein C promote cardiotoxicity
-
Aryal B, Jeong J, Rao VA. Doxorubicin-induced carbonylation and degradation of cardiac myosin binding protein C promote cardiotoxicity. Proc Natl Acad Sci U S A. 2014;111:2011-2016. doi: 10.1073/ pnas.1321783111.
-
(2014)
Proc Natl Acad Sci U S A.
, vol.111
, pp. 2011-2016
-
-
Aryal, B.1
Jeong, J.2
Rao, V.A.3
-
32
-
-
84893845965
-
Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
-
Ichikawa Y, Ghanefar M, Bayeva M, Wu R, Khechaduri A, Naga Prasad SV, Mutharasan RK, Naik TJ, Ardehali H. Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation. J Clin Invest. 2014;124:617-630. doi: 10.1172/JCI72931.
-
(2014)
J Clin Invest.
, vol.124
, pp. 617-630
-
-
Ichikawa, Y.1
Ghanefar, M.2
Bayeva, M.3
Wu, R.4
Khechaduri, A.5
Naga Prasad, S.V.6
Mutharasan, R.K.7
Naik, T.J.8
Ardehali, H.9
-
33
-
-
84884204152
-
Complications of chemotherapy, a basic science update
-
Mazevet M, Moulin M, Llach-Martinez A, Chargari C, Deutsch E, Gomez AM, Morel E. Complications of chemotherapy, a basic science update. Presse Med. 2013;42:e352-361.
-
(2013)
Presse Med.
, vol.42
, pp. e352-361
-
-
Mazevet, M.1
Moulin, M.2
Llach-Martinez, A.3
Chargari, C.4
Deutsch, E.5
Gomez, A.M.6
Morel, E.7
-
34
-
-
15944390579
-
Induction of caspase-independent apoptosis in H9c2 cardiomyocytes by adriamycin treatment
-
Youn HJ, Kim HS, Jeon MH, Lee JH, Seo YJ, Lee YJ, Lee JH. Induction of caspase-independent apoptosis in H9c2 cardiomyocytes by adriamycin treatment. Mol Cell Biochem. 2005;270:13-19.
-
(2005)
Mol Cell Biochem.
, vol.270
, pp. 13-19
-
-
Youn, H.J.1
Kim, H.S.2
Jeon, M.H.3
Lee, J.H.4
Seo, Y.J.5
Lee, Y.J.6
Lee, J.H.7
-
35
-
-
33745312299
-
Doxorubicin induces apoptosis by activation of caspase-3 in cultured cardiomyocytes in vitro and rat cardiac ventricles in vivo
-
Ueno M, Kakinuma Y, Yuhki K, Murakoshi N, Iemitsu M, Miyauchi T, Yamaguchi I. Doxorubicin induces apoptosis by activation of caspase-3 in cultured cardiomyocytes in vitro and rat cardiac ventricles in vivo. J Pharmacol Sci. 2006;101:151-158.
-
(2006)
J Pharmacol Sci.
, vol.101
, pp. 151-158
-
-
Ueno, M.1
Kakinuma, Y.2
Yuhki, K.3
Murakoshi, N.4
Iemitsu, M.5
Miyauchi, T.6
Yamaguchi, I.7
-
36
-
-
9144238766
-
Doxorubicin treatment in vivo activates caspase-12 mediated cardiac apoptosis in both male and female rats
-
Jang YM, Kendaiah S, Drew B, Phillips T, Selman C, Julian D, Leeuwenburgh C. Doxorubicin treatment in vivo activates caspase-12 mediated cardiac apoptosis in both male and female rats. FEBS Lett. 2004;577:483-490. doi: 10.1016/j.febslet.2004.10.053.
-
(2004)
FEBS Lett.
, vol.577
, pp. 483-490
-
-
Jang, Y.M.1
Kendaiah, S.2
Drew, B.3
Phillips, T.4
Selman, C.5
Julian, D.6
Leeuwenburgh, C.7
-
37
-
-
49749108197
-
Sexspecific pathways in early cardiac response to pressure overload in mice
-
(Berlin, Germany).
-
Witt H, Schubert C, Jaekel J, Fliegner D, Penkalla A, Tiemann K, Stypmann J, Roepcke S, Brokat S, Mahmoodzadeh S, Brozova E, Davidson MM, Ruiz Noppinger P, Grohe C, Regitz-Zagrosek V. Sexspecific pathways in early cardiac response to pressure overload in mice. J Mol Med (Berlin, Germany). 2008;86:1013-1024.
-
(2008)
J Mol Med
, vol.86
, pp. 1013-1024
-
-
Witt, H.1
Schubert, C.2
Jaekel, J.3
Fliegner, D.4
Penkalla, A.5
Tiemann, K.6
Stypmann, J.7
Roepcke, S.8
Brokat, S.9
Mahmoodzadeh, S.10
Brozova, E.11
Davidson, M.M.12
Ruiz Noppinger, P.13
Grohe, C.14
Regitz-Zagrosek, V.15
-
38
-
-
34848890055
-
Coactivators PGC-1beta and SRC-1 interact functionally to promote the agonist activity of the selective estrogen receptor modulator tamoxifen
-
Kressler D, Hock MB, Kralli A. Coactivators PGC-1beta and SRC-1 interact functionally to promote the agonist activity of the selective estrogen receptor modulator tamoxifen. J Biol Chem. 2007;282:26897-26907. doi: 10.1074/jbc.M705596200.
-
(2007)
J Biol Chem.
, vol.282
, pp. 26897-26907
-
-
Kressler, D.1
Hock, M.B.2
Kralli, A.3
-
39
-
-
84856470679
-
PGC-1 coactivators in the cardiovascular system
-
Patten IS, Arany Z. PGC-1 coactivators in the cardiovascular system. Trends Endocrinol Metab. 2012;23:90-97. doi: 10.1016/j.tem.2011.09.007.
-
(2012)
Trends Endocrinol Metab.
, vol.23
, pp. 90-97
-
-
Patten, I.S.1
Arany, Z.2
-
40
-
-
0141634243
-
Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles
-
Garnier A, Fortin D, Delomenie C, Momken I, Veksler V, Ventura-Clapier R. Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J Physiol. 2003;551:491-501.
-
(2003)
J Physiol.
, vol.551
, pp. 491-501
-
-
Garnier, A.1
Fortin, D.2
Delomenie, C.3
Momken, I.4
Veksler, V.5
Ventura-Clapier, R.6
-
41
-
-
77952430578
-
Control by circulating factors of mitochondrial function and transcription cascade in heart failure: A role for endothelin-1 and angiotensin II
-
Garnier A, Zoll J, Fortin D, N'Guessan B, Lefebvre F, Geny B, Mettauer B, Veksler V, Ventura-Clapier R. Control by circulating factors of mitochondrial function and transcription cascade in heart failure: a role for endothelin-1 and angiotensin II. Circ Heart Fail. 2009;2:342-350. doi: 10.1161/CIRCHEARTFAILURE.108.812099.
-
(2009)
Circ Heart Fail.
, vol.2
, pp. 342-350
-
-
Garnier, A.1
Zoll, J.2
Fortin, D.3
N'guessan, B.4
Lefebvre, F.5
Geny, B.6
Mettauer, B.7
Veksler, V.8
Ventura-Clapier, R.9
-
42
-
-
0038682372
-
Characterization of the human, mouse and rat PGC1 beta (peroxisome-proliferator-activated receptor-gamma co-activator 1 beta) gene in vitro and in vivo
-
Meirhaeghe A, Crowley V, Lenaghan C, Lelliott C, Green K, Stewart A, Hart K, Schinner S, Sethi JK, Yeo G, Brand MD, Cortright RN, O'Rahilly S, Montague C, Vidal-Puig AJ. Characterization of the human, mouse and rat PGC1 beta (peroxisome-proliferator-activated receptor-gamma co-activator 1 beta) gene in vitro and in vivo. Biochem J. 2003;373(Pt 1):155-165. doi: 10.1042/BJ20030200.
-
(2003)
Biochem J.
, vol.373
, pp. 155-165
-
-
Meirhaeghe, A.1
Crowley, V.2
Lenaghan, C.3
Lelliott, C.4
Green, K.5
Stewart, A.6
Hart, K.7
Schinner, S.8
Sethi, J.K.9
Yeo, G.10
Brand, M.D.11
Cortright, R.N.12
O'rahilly, S.13
Montague, C.14
Vidal-Puig, A.J.15
-
43
-
-
0037127204
-
Peroxisome proliferator-activated receptor gamma coactivator 1beta (PGC-1beta), a novel PGC-1-related transcription coactivator associated with host cell factor
-
Lin J, Puigserver P, Donovan J, Tarr P, Spiegelman BM. Peroxisome proliferator-activated receptor gamma coactivator 1beta (PGC-1beta), a novel PGC-1-related transcription coactivator associated with host cell factor. J Biol Chem. 2002;277:1645-1648. doi: 10.1074/jbc.C100631200.
-
(2002)
J Biol Chem.
, vol.277
, pp. 1645-1648
-
-
Lin, J.1
Puigserver, P.2
Donovan, J.3
Tarr, P.4
Spiegelman, B.M.5
-
44
-
-
80052970004
-
PGC-1 deficiency accelerates the transition to heart failure in pressure overload hypertrophy
-
Riehle C, Wende AR, Zaha VG, Pires KM, Wayment B, Olsen C, Bugger H, Buchanan J, Wang X, Moreira AB, Doenst T, Medina-Gomez G, Litwin SE, Lelliott CJ, Vidal-Puig A, Abel ED. PGC-1 deficiency accelerates the transition to heart failure in pressure overload hypertrophy. Circ Res. 2011;109:783-793. doi: 10.1161/ CIRCRESAHA.111.243964.
-
(2011)
Circ Res.
, vol.109
, pp. 783-793
-
-
Riehle, C.1
Wende, A.R.2
Zaha, V.G.3
Pires, K.M.4
Wayment, B.5
Olsen, C.6
Bugger, H.7
Buchanan, J.8
Wang, X.9
Moreira, A.B.10
Doenst, T.11
Medina-Gomez, G.12
Litwin, S.E.13
Lelliott, C.J.14
Vidal-Puig, A.15
Abel, E.D.16
-
45
-
-
84880166032
-
Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice
-
Dolinsky VW, Rogan KJ, Sung MM, Zordoky BN, Haykowsky MJ, Young ME, Jones LW, Dyck JR. Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice. Am J Physiol. 2013;305:E243-253.
-
(2013)
Am J Physiol.
, vol.305
, pp. E243-253
-
-
Dolinsky, V.W.1
Rogan, K.J.2
Sung, M.M.3
Zordoky, B.N.4
Haykowsky, M.J.5
Young, M.E.6
Jones, L.W.7
Dyck, J.R.8
-
46
-
-
79952648269
-
Activation of mitochondrial energy metabolism protects against cardiac failure
-
Schulz TJ, Westermann D, Isken F, Voigt A, Laube B, Thierbach R, Kuhlow D, Zarse K, Schomburg L, Pfeiffer AF, Tschöpe C, Ristow M. Activation of mitochondrial energy metabolism protects against cardiac failure. Aging (Albany NY). 2010;2:843-853.
-
(2010)
Aging (Albany NY).
, vol.2
, pp. 843-853
-
-
Schulz, T.J.1
Westermann, D.2
Isken, F.3
Voigt, A.4
Laube, B.5
Thierbach, R.6
Kuhlow, D.7
Zarse, K.8
Schomburg, L.9
Pfeiffer, A.F.10
Tschöpe, C.11
Ristow, M.12
-
47
-
-
84862301097
-
Metformin rescues the myocardium from doxorubicin-induced energy starvation and mitochondrial damage in rats
-
Ashour AE, Sayed-Ahmed MM, Abd-Allah AR, Korashy HM, Maayah ZH, Alkhalidi H, Mubarak M, Alhaider A. Metformin rescues the myocardium from doxorubicin-induced energy starvation and mitochondrial damage in rats. Oxid Med Cell Longev. 2012;2012:434195. doi: 10.1155/2012/434195.
-
(2012)
Oxid Med Cell Longev.
, vol.2012
, pp. 434195
-
-
Ashour, A.E.1
Sayed-Ahmed, M.M.2
Abd-Allah, A.R.3
Korashy, H.M.4
Maayah, Z.H.5
Alkhalidi, H.6
Mubarak, M.7
Alhaider, A.8
-
48
-
-
78751554136
-
Adiponectin protects against doxorubicin-induced cardiomyopathy by anti-apoptotic effects through AMPK up-regulation
-
Konishi M, Haraguchi G, Ohigashi H, Ishihara T, Saito K, Nakano Y, Isobe M. Adiponectin protects against doxorubicin-induced cardiomyopathy by anti-apoptotic effects through AMPK up-regulation. Cardiovasc Res. 2011;89:309-319. doi: 10.1093/cvr/cvq335.
-
(2011)
Cardiovasc Res.
, vol.89
, pp. 309-319
-
-
Konishi, M.1
Haraguchi, G.2
Ohigashi, H.3
Ishihara, T.4
Saito, K.5
Nakano, Y.6
Isobe, M.7
-
49
-
-
84858782079
-
AMPK: A nutrient and energy sensor that maintains energy homeostasis
-
Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 2012;13:251-262. doi: 10.1038/nrm3311.
-
(2012)
Nat Rev Mol Cell Biol.
, vol.13
, pp. 251-262
-
-
Hardie, D.G.1
Ross, F.A.2
Hawley, S.A.3
-
50
-
-
0025193951
-
Structure of the adriamycin-cardiolipin complex
-
Goormaghtigh E, Huart P, Praet M, Brasseur R, Ruysschaert JM. Structure of the adriamycin-cardiolipin complex. Role in mitochondrial toxicity. Biophys Chem. 1990;35:247-257.
-
(1990)
Role in Mitochondrial Toxicity. Biophys Chem.
, vol.35
, pp. 247-257
-
-
Goormaghtigh, E.1
Huart, P.2
Praet, M.3
Brasseur, R.4
Ruysschaert, J.M.5
|